色谱-质谱联用技术鉴定盐酸咪达唑仑的有关物质

金瑞; 闫若凝; 陆宇婷; 宋敏; 杭太俊

doi:10.11665/j.issn.1000-5048.20200309

色谱-质谱联用技术鉴定盐酸咪达唑仑的有关物质

中国药科大学药物分析系，南京 210009

计量
- 文章访问数: 281
- HTML全文浏览量: 3
- PDF下载量: 536
出版历程
- 收稿日期: 2020-03-24
- 修回日期: 2020-04-27
- 刊出日期: 2020-06-24

Identification of related substances of midazolam hydrochloride by LC-MS

摘要

摘要: 色谱-质谱联用（LC-MS）技术鉴定盐酸咪达唑仑中的有关物质。采用Thermo BDS Hypersil C₁₈ (100 mm×4.6 mm，2.4 μm)色谱柱，以乙腈-25 mmol/L醋酸铵水溶液(冰醋酸调节pH为5.5)为流动相梯度洗脱，对盐酸咪达唑仑有关物质进行分离，电喷雾正离子化-四极杆-飞行时间串联质谱(ESI-Q-TOF/MS)高分辨测定各有关物质母离子及其子离子的准确质量和元素组成，通过光谱解析并结合合成工艺分析鉴定了它们的结构，并对部分杂质进一步采用对照品对照确证。在所建立的分析条件下，盐酸咪达唑仑及其有关物质分离良好，检测并鉴定出盐酸咪达唑仑及其强制降解试验样品中22个主要有关物质，其中8个为美国药典规定的已知杂质。LC-MS技术能有效地分离鉴定盐酸咪达唑仑中的有关物质，可为其贮存条件制定、生产工艺优化和质量控制提供参考依据。
- 盐酸咪达唑仑 /
- 有关物质 /
- 结构鉴定 /
- 色谱-质谱联用
Abstract: This study aimed to identify the related substances of midazolam hydrochloride by liquid chromatography-mass spectrometry (LC-MS). To separate the related substances of midazolam hydrochloride, gradient elution was performed using acetonitrile and 25 mmol/L of ammonium acetate (pH was adjusted to 5.5 with acetic acid) as mobile phase on Thermo BDS Hypersil C₁₈ column (100 mm × 4.6 mm, 2.4 μm). The accurate mass and elemental composition of the parent ions and their product ions of related substances were determined by electrospray-ionization quadrupole time-of-flight mass spectrometry (ESI-Q-TOF/MS). The structures of the related substances were identified by spectral analysis and process synthesis, and some of them were further confirmed by reference substances. Under the established HPLC condition, midazolam hydrochloride and its related substances were adequately separated, and 22 major related substances were detected and identified by hyphenated techniques in midazolam hydrochloride and its stressed samples, of which 8 were recorded as impurities in the United States Pharmacopeia. The LC-MS techniques can effectively separate and identify the related substances of midazolam hydrochloride and provide reference for the establishment of storage condition, optimization of synthetic processes and quality control.

HTML全文

参考文献(19)

[1]	. Cochrane Database Syst Rev， 2016（5）： CD009491.
[2]	Chen XJ， Mou XQ， He ZY， et al. The effect of midazolam on pain control after knee arthroscopy： a systematic review and meta-analysis［J］. J Orthop Surg Res， 2017， 12（1）： 179.
[3]	Grant MC， Kim J， Page AJ， et al. The effect of intravenous midazolam on postoperative nausea and vomiting： a meta-analysis［J］. Anesth Analg， 2016， 122（3）： 656-663.
[4]	Reddy SD， Reddy DS. Midazolam as an anticonvulsant antidote for organophosphate intoxication： a pharmacotherapeutic appraisal［J］. Epilepsia， 2015， 56（6）： 813-821.
[5]	Shtull-Leber E， Silbergleit R， Meurer WJ. Pre-hospital midazolam for benzodiazepine-treated seizures before and after the rapid anticonvulsant medication prior to arrival trial： a national observational cohort study［J］. PLoS One， 2017， 12（3）： e0173539. doi：10.1371/journal.pone.0173539.
[6]	Dao K， Giannoni E， Diezi M， et al. Midazolam as a first-line treatment for neonatal seizures： retrospective study［J］. Pediatr Int， 2018， 60（5）： 498-500.
[7]	Ng E， Taddio A， Ohlsson A. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit［J］. Cochrane Database Syst Rev， 2017， 1（1）： CD002052.
[8]	Sivaramakrishnan G， Sridharan K. Nitrous oxide and midazolam sedation： a systematic review and meta-analysis［J］. Anesth Prog， 2017， 64（2）： 59-65.
[9]	Santotoribio JD， Parodi Fernández V， Mesa Suárez P. Sedation with midazolam without neurotoxic effects［J］.Med Clin （Barc）， 2018，150（11）：450.
[10]	Cheng X， Chen L， Huang LN， et al. Determination of related substances of midazolam syrup by RP-HPLC［J］. Fujian Anal Test（福建分析测试）， 2010， 19（2）： 76-79.
[11]	Huang CY， Chen MH， Cai M， et al. Preliminary exploration and structure identification of related substances of midazolam injection by 2D-LC-IT-TOF/MS［J］. Chin J Pharm Anal（药物分析杂志）， 2017， 37（4）： 688-694.
[12]	Feng XL， Du G， Hou TY， et al. Characterization of degradation products of midazolam maleate by UHPLC-HR-IT-MSⁿ and NMR［J］. Pharmazie， 2017， 72（2）： 73-80.
[13]	Sati B， Sati H， Saklani S， et al. Synthesis of the impurities during the manufacture of bulk drug midazolam and separation of these impurities by HPLC［J］. Acta Pharm， 2013， 63（3）： 385-396.
[14]	The United States Pharmacopeia Convention. United States Pharmacopeia 43［S］. Rockville：The United States Pharmacopeia Convention， 2020： 2952-2953．
[15]	Guo JF， Shan XY， Shi HL.Graphical synthetic routes of midazolam［J］. Chin J Pharm （中国医药工业杂志）， 2012，43（5）：82-84.
[16]	Fu YG， Li L， Li J， et al. Study on conjugated system of midazolam［J］. Chem Bioeng （化学与生物工程）， 2010， 27（10）： 31-32， 36.
[17]	Hou XY. Study on the stability of midazolam syrup solution（咪达唑仑糖浆混合液稳定性研究）［D］. Bejing：Peking Union Medical College， 2017.
[18]	Yin XY， Wang C， Ming GJ， et al. Identification of the related substances in pioglitazone hydrochloride by hyphenated LC-MS techniques［J］. J China Pharm Univ（中国药科大学学报）， 2017， 48（6）： 701-710.
[19]	Ni YL， Han X， Song M， et al. Identification of the related substances of cyclosporin A by LC-MS techniques［J］. J China Pharm Univ（中国药科大学学报）， 2019， 50（4）： 423-437.

施引文献(2)

期刊类型引用(0)

其他类型引用(2)

资源附件(0)

计量

文章访问数: 281
HTML全文浏览量: 3
PDF下载量: 536
被引次数: 2

色谱-质谱联用技术鉴定盐酸咪达唑仑的有关物质

计量

出版历程

Identification of related substances of midazolam hydrochloride by LC-MS

期刊类型引用(0)

其他类型引用(2)

计量

出版历程

目录